POLOPAN-C CAPSULES
Composition: Each capsule contains Pantoprazole 40 mg and Cinitapride 3 mg.
Therapeutic Class: Proton Pump Inhibitor (PPI) and Gastrointestinal Prokinetic Agent.
Mechanism of Action: Pantoprazole inhibits the gastric H+/K+-ATPase proton pump, reducing gastric acid secretion. Cinitapride enhances gastrointestinal motility and supports gastric emptying.
Indications: Gastroesophageal Reflux Disease (GERD), functional dyspepsia, heartburn, acid-related upper abdominal discomfort, and reflux symptoms associated with impaired gastrointestinal motility.
Dosage and Administration: Adults: One capsule once daily, preferably before breakfast, only as prescribed by the physician. The dose and duration should be individualized according to the patient's condition and the approved product information. Swallow the capsule whole unless the product label states otherwise.
Contraindications: Hypersensitivity to either active ingredient, gastrointestinal obstruction, perforation or hemorrhage, and other contraindications specified in the approved prescribing information.
Precautions: Use cautiously in patients with significant hepatic or renal impairment. Pregnancy and breastfeeding require medical assessment. Review concomitant medications and the patient's medical history before treatment.
Adverse Effects: Headache, abdominal discomfort, nausea, diarrhea, constipation, and dizziness may occur.
Storage: Store in a cool, dry place, protected from light and moisture, according to the manufacturer's instructions.
Presentation: Capsules containing Pantoprazole 40 mg and Cinitapride 3 mg.
POLOPAN-C combines acid suppression with prokinetic activity to support the management of acid reflux and functional dyspeptic symptoms.
For prescription use under medical supervision. Confirm the final composition and approved dosage before printing.
Company: UNIMAX